Dairy
MSD completes $55 million acquisition of Vecoxan
MSD Animal Health has completed its $55 million acquisition of the worldwide rights to Vecoxan (diclazuril), an oral suspension for...
Dairy
MSD Animal Health has completed its $55 million acquisition of the worldwide rights to Vecoxan (diclazuril), an oral suspension for...
Agri-Business
The European Commission has granted approval to Elanco Animal Health’s pending acquisition of Bayer’s animal health business. Elanco, the US-based...